yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Table
SPARQL
Graphs
2
2
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30476899-E55F993F-D2AF-442F-83C7-87A5A0EE1AB4
Q30476899-E55F993F-D2AF-442F-83C7-87A5A0EE1AB4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30476899-E55F993F-D2AF-442F-83C7-87A5A0EE1AB4
Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome
P2860
Q30476899-E55F993F-D2AF-442F-83C7-87A5A0EE1AB4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30476899-E55F993F-D2AF-442F-83C7-87A5A0EE1AB4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ca75746d81c9c65ba62df01b412e87a070e95ab9
P2860
Latent transforming growth factor-beta: structural features and mechanisms of activation